MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$7,206,990
(1.37%↑ Y/Y)
Pre-tax loss
-$7,206,990
(1.37%↑ Y/Y)
Other income
$433,227
(17.04%↑ Y/Y)
Loss from operations
-$7,640,217
(0.48%↑ Y/Y)
Collaboration revenue
$251,147
(-2.61%↓ Y/Y)
Total operating
expenses
$7,891,364
(-0.55%↓ Y/Y)
Research and development
$4,096,580
(-21.43%↓ Y/Y)
General and
administrative
$3,781,977
(39.36%↑ Y/Y)
In-process research and
development
$10,000
Depreciation
$2,807
(-58.96%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Coya Therapeutics, Inc. (COYA)
Coya Therapeutics, Inc. (COYA)